Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin by Ng, Dominic Chi Hiung et al.
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
Y
JCB: ARTICLE
© The Rockefeller University Press    $8.00
The Journal of Cell Biology, Vol. 172, No. 2, January 16, 2006 245–257
http://www.jcb.org/cgi/doi/10.1083/jcb.200503021 JCB 245
Introduction
The STAT (signal transducer and activator of transcription) 
family is comprised of seven members in mammals, of which 
Stat3 is the most pleiotropic member implicated in several bio-
logical processes (Levy and Lee, 2002). Specifi  cally, it has been 
established as an oncogene by cell transformation and tumor 
formation capacities in gain-of-function studies (Bromberg et  al., 
1999; Bromberg, 2002). In addition, constitutive Stat3 activa-
tion has been reported in a multitude of human cancers (Bow-
man et al., 2000). The oncogenic potential of Stat3 was initially 
attributed to a positive infl  uence on cell proliferation and/or 
protection from cell death (for review see Bromberg and Dar-
nell, 2000). However, a multifunctional role for Stat3 in pro-
moting tumor growth is emerging, with Stat3 implicated in 
mediating cell motility and invasiveness, nutrient supply through 
augmenting angiogenesis, and in masking tumors from the 
body’s innate immune defenses (Wei et al., 2003; Silver et al., 
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2004; Wang et al., 2004). In addition to tumorigenesis, Stat3 
knockout in mice causes early embryonic lethality (Takeda 
et al., 1997). Furthermore, conditional knockout mice revealed 
a critical role for Stat3 in migrating keratinocytes involved in 
wound healing of the skin (Sano et al., 1999). These studies, in 
addition to conditional Stat3 ablation studies in other tissues 
(Akira, 2000; Levy and Lee, 2002), indicate that Stat3 function 
extends beyond its tumorigenic potential.
Despite the wide range in function, the molecular events 
leading to Stat3 activation remain relatively straightforward. 
The canonical Stat3 activation pathway involves cytokine-
  induced receptor subunit multimerization and activation of recep-
tor-associated Janus tyrosine kinases at the intracellular domain 
(Darnell et al., 1994). Janus tyrosine kinase phosphorylation of 
the receptor subunits subsequently recruits latent Stat3 from the 
cytoplasm via Src homology 2 domain interaction (Heim et al., 
1995). In turn, Stat3 is phosphorylated, dimerizes, and nuclear 
translocates to regulate gene expression. Several Stat3 target 
genes have been identifi  ed, including cyclin D1, c-myc, Bcl-2, 
and Bcl-XL (Turkson and Jove, 2000), which may be critical in 
Stat3-mediated tumorigenesis by regulating cell cycle and 
  survival. However, it remains unclear how Stat3 regulates cell 
  migration. In addition, it is unclear whether cytoplasmic Stat3, 
the majority of Stat3 population in normal cells, plays any role 
independent of its transcriptional activity.
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S
tat3 is a member of the signal transducer and ac-
tivator of transcription family, which is important in 
cytokine signaling. Gene ablation studies have re-
vealed a requirement for Stat3 in diverse biological pro-
cesses (Akira, S. 2000. Oncogene. 19: 2607–2611; Levy, 
D.E., and C.K. Lee. 2002. J. Clin. Invest. 109:1143–1148). 
Previously, the function of Stat3 had been attributed exclu-
sively to its transcriptional activity in the nucleus. In this 
study, we reveal an interaction between Stat3 and the 
microtubule (MT)-destabilizing protein stathmin. Stathmin 
did not overtly affect ligand-stimulated Stat3 activation.
In contrast, the expression of Stat3 is required for the 
stabilization of MTs and cell migration. We further dem-
onstrate that Stat3-containing cells are resistant to the 
MT-destabilizing effect of stathmin overexpression. In 
addition, down-regulation of stathmin protein levels in 
Stat3-deﬁ  cient cells partially reversed the MT and migration 
deﬁ  ciencies. Recombinant Stat3 was also capable of revers-
ing stathmin inhibition of tubulin polymerization in vitro.
Our results indicate that Stat3 modulates the MT network by
binding to the COOH-terminal tubulin-interacting domain 
of stathmin and antagonizing its MT destabilization activity.T
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Stathmin, also known as oncoprotein 18, is a small (18 kD) 
ubiquitous phosphoprotein localized predominantly to the cyto-
sol. The related stathmin-like family members include super 
cervical ganglion protein 10 (SCG10), SCG10-like protein 
(SCLIP), and RB3. These stathmin-related proteins share highly 
homologous tubulin-binding stathmin-like domains (SLDs) at 
their COOH terminus (Charbaut et al., 2001). In addition, they 
possess a variable membrane-anchoring NH2-terminal region 
that localizes the proteins predominantly to the Golgi apparatus 
(Gavet et al., 1998).
Stathmin was originally identifi  ed as a key factor involved 
in regulating cell proliferation (Sobel et al., 1989). More re-
cently, stathmin’s ability to bind α/β-tubulin heterodimers to 
facilitate the depolymerization of microtubules (MTs; Belmont 
and Mitchison, 1996) was identifi  ed as a principle mechanism 
of action associated with the control of mitotic spindle assem-
bly as well as other processes involving MT dynamics (Marklund 
et al., 1994; Iancu et al., 2001). Of particular relevance to this 
study are previous reports of the contribution of stathmin to cell 
motility (Baldassarre et al., 2005; Giampietro et al., 2005). 
However, the exact mechanism by which stathmin mediates this 
process remains unclear. Because of their compartmental re-
strictions, the functions of stathmin-like proteins are likely to be 
more specifi  ed compared with stathmin, although this also re-
mains largely uncharacterized.
In this study, we present evidence of Stat3 interacting with 
stathmin. Moreover, our results reveal that Stat3 may modulate 
MT dynamics and cell migration through a direct functional in-
teraction with stathmin in the cytoplasm.
Results
Stathmin is a Stat3-interacting protein
We initially identifi  ed SCLIP as an interacting protein of Stat3 
in a yeast two-hybrid screen of a mouse brain library using the 
COOH-terminal portion of Stat3 (aa 395–770) as bait. The in-
teraction between exogenously expressed proteins was subse-
quently confi   rmed in mammalian COS-1 cells (unpublished 
data). Next, we tested for an interaction with Stat3 among other 
members of the stathmin family. We observed that myc-tagged 
SCLIP and stathmin but not myc-SCG10 was shown to associ-
ate with endogenous Stat3 in PC12 cells (Fig. 1 A). Because the 
biological functions of stathmin are better characterized com-
pared with SCLIP, we focused our study on stathmin. As a result 
of the high expression of stathmin in neuronal cells, the endog-
enous association with Stat3 was tested in PC12 and NSC34 
cells. The results showed that endogenous stathmin coimmuno-
precipitated with the Stat3-specifi  c antibody but not rabbit IgG 
in both cell lines (Fig. 1 B). Finally, we sought to determine 
whether the interaction between Stat3 and stathmin was direct. 
GST-stathmin was expressed and purifi  ed  from  Escherichia 
coli, and its interaction with a baculovirus-produced His-tagged 
Stat3 was examined. Fig. 1 C shows that His-Stat3 (97 kD) and 
GST-stathmin (46 kD) are the major proteins in the Coomassie 
blue–stained gel. Association between His-tagged Stat3 and 
GST-stathmin was then determined by a pull-down assay with 
glutathione–Sepharose beads. In Fig. 1 D, a marginal amount 
of Stat3 was found associating with the GST. However, 
substantially greater amounts of Stat3 were pulled down by 
GST-stathmin. To exclude the possibility that stathmin associ-
ated with the His-tag nonspecifi  cally, we showed that both GST 
alone and GST-stathmin did not interact with an irrelevant 
His-tagged protein, His-COMT (catechol-O-methyltransferase; 
Fig. 1 E). Altogether, these results demonstrate a direct physio-
logical association of Stat3 with stathmin.
Stathmin proteins do not affect 
Stat3 signaling
To determine the function of Stat3 association with stathmin 
proteins, we fi  rst investigated the effect of modulating stathmin ex-
pression on Stat3 signaling. Overexpression of myc-stathmin or 
short inhibitory RNA (siRNA) down-regulation of endogenous 
stathmin in PC12 cells did not signifi  cantly affect Stat3 tran-
scriptional activity stimulated by interleukin (IL)-6, as deter-
mined by a luciferase reporter assay (Fig. 2, A and B). In addition, 
stimulated Stat3 Y705 and S727 phosphorylation remained un-
changed during overexpression (not depicted) or knockdown of 
stathmin protein (Fig. 2 C). Finally, we showed that stathmin 
overexpression did not prevent Stat3 nuclear translocation 
  stimulated by IL-6 (Fig. 2 D). Collectively, these experiments 
demonstrate that stathmin does not augment or perturb ligand-
stimulated Stat3 signaling in terms of phosphorylation, capacity 
of nuclear translocation, and promoting transcription.
Stat3-deﬁ  cient (∆St3) MEF cells exhibit 
an impaired MT network
We next investigated whether an interaction with Stat3 infl  u-
enced stathmin activity by fi  rst looking at the MT network in 
murine embryonic fi  broblasts (MEFs) genetically depleted of 
Stat3 (Costa-Pereira et al., 2002). Staining for α-tubulin re-
vealed radial arrays of MTs in the wild-type (WT) MEF cells 
(Fig. 3 A, i). Strikingly, the MT array in ∆St3 MEFs appeared 
disorganized, with thin, discontinuous fi  laments and few MTs 
radiating from the centrosome to the plasma membrane (Fig. 
3 A, iv). Quantitative analysis of the α-tubulin staining in ran-
domly selected cells indicated that the fl  uorescence intensity in 
∆St3 MEFs (40 ± 14 intensity units/μm
2; n = 12) were  40% 
of that in WT MEFs (94 ± 18 intensity units/ μm
2; n = 12; not 
depicted). Further analysis with anti-acetylated α-tubulin re-
vealed dramatically reduced levels of this MT subset in ∆St3 
MEFs compared with WT cells (Fig. 3 A, ii and v). Further-
more, we compared MTs at the same cell cycle stage by arrest-
ing cells at the G1/S transition with hydroxyurea (HU). Arresting 
WT MEFs with HU resulted in substantially increased acety-
lated MTs (Fig. 3 A, iii). In contrast, ∆St3 cells displayed a 
marginal increase after HU treatment (Fig. 3 A, vi). As post-
translational acetyl modifi  cation correlates with increased MT 
stability (Webster and Borisy, 1989), these results indicate that 
the ∆St3 MEFs are defi  cient in stabilized long-life MTs. We 
further confi  rmed this biochemically. Initially, we examined the 
total   expression of α-tubulin and acetylated α-tubulin in MEF 
cells. Densitometric quantitation of α-tubulin bands, normal-
ized for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
expression, indicated that there was not a marked difference T
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 between  ∆St3 and WT MEFs. In contrast, acetylated α-tubulin 
levels after normalizing for GAPDH expression were  35% 
lower in ∆St3 MEFs compared with WT. Stat3 was also con-
fi  rmed to be absent in ∆St3 MEFs (Fig. 3 B).
As MTs are denatured during the preparation of total cell 
lysates (TCLs), we next investigated the levels of tubulin poly-
mers specifi  cally by harvesting cells in a MT-stabilizing buffer 
and performing differential sedimentation of polymerized tubu-
lin from free tubulin. These results indicated that the amount of 
α-tubulin polymers in the pellet fraction of ∆St3 MEFs was 
substantially reduced with a concomitant increase of free 
α-  tubulin in the soluble fraction when compared with WT cells 
(Fig. 3 C, top). Similarly, the amount of acetylated α-tubulin poly-
mers in ∆St3 MEF cells was reduced (Fig. 3 C, second panel). 
  Reprobing with an antibody for GAPDH indicated equivalent 
protein loading between samples (Fig. 3 C, third panel). Den-
sitometric analysis indicated similar total levels of tubulin (i.e., 
soluble and pellet fractions combined) between the MEF cells 
(not depicted). In addition, Stat3 in WT MEFs was predomi-
nantly located in the soluble fraction and did not pellet down 
with MTs (Fig. 3 C, fourth panel), suggesting that Stat3 is not 
directly associated with MTs in vivo. To confi  rm the specifi  city 
of this method, we pretreated WT MEFs with taxol or no-
codazole before harvesting. As shown in Fig. 3 C (bottom), the 
majority of α-tubulin in taxol-pretreated cells was found in 
the pellet. Conversely, no α-tubulin was found in the pellet of 
  nocodazole-pretreated cells. This confi   rms the polymerized 
state of tubulin found in the pellet fractions.
To exclude the possibility that the differences in tubulin 
polymer content was caused by a change in cell cycle state in 
the ∆St3 cells, we measured the DNA content of ∆St3 com-
pared with WT MEFs by propidium iodide staining and cell 
sorting. The percentages of cells in the various cell cycle states 
did not differ markedly between the two cell types (Fig. 3 D). 
Finally, as MTs infl  uence cell motility, we assessed ∆St3 MEF 
cell migration and demonstrated a severely reduced capacity to 
migrate into an in vitro wound track (Fig. 3 E). This is in agree-
ment with previous reports of Stat3 function in regulating cell 
motility (Sano et al., 1999). Collectively, our data demonstrate 
that Stat3 ablation in MEF cells results in a perturbed MT net-
work and impaired cell migration.
Stat3 expression promotes MT formation
To determine whether Stat3 expression could promote MT for-
mation, we reintroduced Stat3 into ∆St3 MEFs by retroviral in-
fection. Reexpression of Stat3 restored the level of acetylated 
MTs in ∆St3 MEFs to a level comparable with WT cells (Fig. 
4 A). In addition, the amount of polymerized α-tubulin in retro-
virally infected ∆St3 MEFs was elevated above that of unin-
fected cells (or ∆St3 MEFs infected with retrovirus vector) and 
was comparable with that in WT MEFs (Fig. 4 B). Reprobing 
for Stat3 confi  rmed reexpression in cells infected with Stat3 ret-
rovirus only, and reprobing for GAPDH demonstrated equiva-
lent protein loading.
To further characterize Stat3 regulation of MT stability 
in other cell types, endogenous Stat3 was down-regulated in 
Figure 1.  Association of Stat3 with stathmin. (A) PC12 cells were transfected with myc-tagged SCLIP, SCG10, and stathmin or vector alone. Endogenous 
Stat3 was immunoprecipitated, and the associated proteins were evaluated by blotting with anti-myc. The expression of myc-tagged proteins in total cell 
lysates (TCLs) was also determined by Western blotting. (B) Association of endogenous stathmin with Stat3 in PC12 and NSC34 cells was determined by 
immunoprecipitation with Stat3 antibody and blotting for stathmin. Substitution of the Stat3 antibody with a normal rabbit IgG antibody served as a   control. 
Protein expression levels of Stat3 and stathmin in TCLs were analyzed. (C) Puriﬁ  ed recombinant His-tagged Stat3 and GST-stathmin were Coomassie blue 
stained. (D) 3 μg His-tagged Stat3 and 3 μg GST-stathmin were preincubated and subjected to a GST pull-down assay. Interaction with GST-stathmin was 
then determined by blotting with anti-Stat3. Pull-down efﬁ  ciency was shown by blotting for GST. GST alone was used as a negative control. An aliquot 
of each reaction before pull-down was similarly blotted to indicate protein input. (E) GST-stathmin pull-down was repeated with an irrelevant His-tagged 
protein (His-COMT).JCB • VOLUME 172 • NUMBER 2 • 2006  248
MCF-7 cells by transient expression of a human Stat3 siRNA 
sequence. As a control, transfection with the empty siRNA vec-
tor did not affect Stat3 expression or acetylated MTs (Fig. 4 C, 
i–iii). In contrast, MCF-7 cells with reduced Stat3 expression 
exhibited a decrease in the amount of acetylated MTs (Fig. 4 C, 
iv–vi; arrows). Finally, we demonstrated that the expression in 
∆St3 MEFs of WT Stat3 or a Stat3 mutant (Y705F) previously 
shown to be defi  cient in transcriptional activity (Kaptein et al., 
1996) induced a normal MT network morphology as detected 
by antibodies against α-tubulin (Fig. 4 D) and acetylated 
α- tubulin (Fig. 4 E). In contrast, a transcriptionally active Stat3 mu-
tant (Stat3C; Bromberg et al., 1999) did not markedly rescue the 
MT network in these cells (Fig. 4, D and E). This suggests that 
the effect of Stat3 on MTs may be independent of the transcrip-
tional activity of the dimer. In support of this, we also found that 
ligand-induced activation of Stat3, as indicated by Y705 or S727 
phosphorylation, had little effect on the polymerized MT mass 
in WT MEFs (Fig. S1 A, available at http://www.jcb.org/cgi/
content/full/jcb.200503021/DC1). Likewise, complete disrup-
tion of the MT network did not perturb ligand-  stimulated Stat3 
tyrosine phosphorylation (Fig. S1 B). In total, these results indi-
cate that the cytosolic expression of Stat3 promotes MT forma-
tion, which may be independent of its nuclear activity.
Stat3 attenuates MT depolymerization 
induced by stathmin in MEFs
We next sought to identify the specifi   c mechanism through 
which Stat3 regulated MT assembly. We could not fi  nd a direct 
association between Stat3 and either α- or β-tubulin in WT 
MEFs (Fig. S2 A, available at http://www.jcb.org/cgi/content/
full/jcb.200503021/DC1). In addition, the MT network was 
not required for Stat3–stathmin interaction, as nocodazole pre-
treatment did not prevent coimmunoprecipitation of stathmin 
with Stat3 (Fig. S2 B). We next investigated whether the 
Stat3–stathmin interaction was involved in modulating MTs. 
We fi rst determined the region of stathmin that was required for 
Stat3 interaction by deleting various amino acids from the NH2 
or COOH terminus of stathmin (Fig. 5 A). These mutants were 
then expressed in WT MEFs, and their interaction with endog-
enous Stat3 was analyzed. Stathmin deletion mutants truncated 
from the COOH terminus (aa 1–120 and 1–90) displayed a 
marked reduction in association with Stat3 in comparison with 
full-length or NH2-terminally (aa 30–150 and 60–150) trun-
cated stathmin (Fig. 5 B). This indicates that Stat3 binds to the 
COOH-terminal region of stathmin, which is also involved in 
binding tubulin. Surprisingly, although Stat3 bound to the full-
length SCLIP, its binding capacity to the SLD of SCLIP (SCLIP-
SLD, aa 38–180) was signifi  cantly reduced (Fig. 5 C). This 
suggests that the NH2 terminus of SCLIP may be also required 
for Stat3 binding. However, because of the loss of membrane-
anchoring cysteine residues, it remains unclear whether Golgi 
localization or the intrinsic presence of the SCLIP NH2 termi-
nus is required for the Stat3 association.
We next investigated Stat3 contribution to MT depolymer-
ization induced by stathmin overexpression in WT compared 
with ∆St3 MEFs. In addition, given the differences in Stat3 
binding, the effect of SCLIP-SLD overexpression was simulta-
neously assessed for comparison. We found that the MT network 
remained largely intact in WT MEFs overexpressing stathmin 
(Fig. 5 D, i–iii). This is in agreement with the previously re-
ported effects of stathmin overexpression on the MT network of 
Xenopus laevis A6 endothelial cells (Niethammer et al., 2004). 
Figure 2.  Effect of stathmin on Stat3 signaling.
(A) PC12 cells were transfected with myc-
tagged stathmin or a vector control (pXJ40-
myc) along with the m67luc construct for a 
reporter gene assay to measure Stat3 tran-
scriptional activity. Relative luciferase activity 
was measured after 8 h of stimulation with 
IL-6. Control samples in all of the panels were 
left unstimulated. (B) PC12 cells expressing 
stathmin siRNA or a vector encoding a random
sequence were measured for IL-6–stimulated 
Stat3 luciferase activity as described in A. 
Error bars represent SEM. (C) PC12 cells ex-
pressing stathmin siRNA or a random vector 
control were stimulated with 100 ng/ml EGF 
or 40 ng/ml IL-6 for 15 min. Stat3 Y705 and 
S727 phosphorylation was then analyzed 
by immunoblotting. Reprobing for total Stat3 
protein levels served as a control for loading. 
Blotting lysates with anti-stathmin showed the 
extent of stathmin down-regulation. (D) PC12 
cells expressing myc-tagged stathmin were 
stimulated with 40 ng/ml IL-6 for 15 min or left 
unstimulated as a control. Stathmin and Stat3 
localization was then determined by indirect 
immunoﬂ   uorescence. Images are shown indi-
vidually or merged. Bar, 20 μm.STAT3 REGULATES MICROTUBULES • NG ET AL. 249
However, the reduced MT network in ∆St3 MEFs was further 
depolymerized by stathmin in ∆St3 cells as indicated by the 
dispersed punctate α-tubulin staining in the positively trans-
fected cell (Fig. 5 D, iv–vi). This different effect of stathmin is 
more clearly displayed in the enlarged images (Fig. 5 D, com-
pare xiii with xiv). In contrast to stathmin, we observed that 
regardless of Stat3 expression, both WT and ∆St3 MEFs over-
expressing SCLIP-SLD showed certain degrees of MT depoly-
merization (Fig. 5 D, vii–xii). The different behavior of stathmin 
and SCLIP-SLD was not caused by the different expression 
level because their expression was comparable in both WT and 
∆St3 MEF cells (Fig. 5 E). These results suggest that endoge-
nous Stat3 may prevent MT disassembly induced by stathmin 
but not SCLIP-SLD overexpression via a functional interaction.
A key factor in a mechanism where Stat3 promotes MT 
formation through an antagonistic interaction with stathmin is 
the presence of suffi  cient Stat3 protein in relation to stathmin. 
Therefore, we determined the absolute intracellular levels of 
Figure 3.  MTs are disrupted in 𝖫St3 MEF 
cells. (A) WT (i–iii) and ∆St3 (iv–vi) MEF cells 
were ﬁ  xed and stained for α-tubulin or acety-
lated α-tubulin as indicated. Cells were also 
treated with 2 μM HU for 24 h before stain-
ing for acetylated α-tubulin (iii and vi). Bar, 
20 μm. (B) Whole cell lysates from WT and 
∆St3 MEF cells were probed with the indi-
cated antibodies. (C) Polymerized tubulin (P) 
was differentially sedimented from soluble tu-
bulin (S) in WT and ∆St3 lysates prepared in 
a MT-stabilizing buffer. Soluble and polymer-
ized tubulin fractions were then analyzed by 
blotting for α-tubulin and acetylated α-tubulin. 
Membranes were then reprobed for Stat3 and 
GAPDH. Tubulin fractions were also differen-
tially extracted from WT MEFs pretreated with 
10 μM taxol (4 h) or 10 μM nocodazole (NZ; 
4 h) and blotted for α-tubulin. (D) WT and 
∆St3 MEFs were stained with 50 μg/ml prop-
idium iodide for cell cycle analysis by ﬂ  ow 
cytometry. M1 corresponds to cells in G1, M2 
to cells in S phase, and M3 corresponds to 
G2/M phase. (E) WT and ∆St3 MEF cells were 
seeded at conﬂ  uency and subjected to scratch 
wounding. Wound closure was evaluated and 
recorded after 24 h.JCB • VOLUME 172 • NUMBER 2 • 2006  250
Stat3 and stathmin protein in PC12 cells. There was roughly 2.5 
times the number of cellular Stat3 to stathmin (Fig. S3, A–E; 
available at http://www.jcb.org/cgi/content/full/jcb.200503021/
DC1). In MEFs, the estimated ratio of Stat3 versus stathmin was 
even higher (not depicted). These results indicate that intracellu-
lar Stat3 is present in suffi  cient amounts and is capable of pre-
venting the disassembly of MTs induced by an interacting partner 
(stathmin) but not the noninteracting SCLIP-SLD protein.
Down-regulation of stathmin partially 
restores the impaired MT network and 
migration observed in 𝖫St3 cells
Next, we down-regulated endogenous stathmin expression by 
siRNA to further investigate its contribution to disrupting MTs 
in ∆St3 cells. We fi  rst demonstrated that stathmin knockdown 
did not overtly affect the level of polymerized α-tubulin in WT 
MEFs (Fig. 6 A). However, transient expression of increasing 
amounts of stathmin siRNA induced an increase in polymerized 
α-tubulin levels in ∆St3 MEFs (Fig. 6 B). Densitometric quan-
titation indicated that in WT MEFs expressing control siRNA, 
polymerized α-tubulin in WT MEFs represented 61 ± 0.4% 
of total α-tubulin (Fig. 6 C). In contrast, polymerized tubulin 
was found to make up only 17 ± 3.8% of total tubulin in ∆St3 
MEFs expressing control siRNA. This increased to 39 ± 1.9% 
in ∆St3 MEFs transfected with the highest amount of stathmin 
siRNA used, which was signifi  cantly elevated (P < 0.005), 
compared with cells expressing control siRNA (Fig. 6 C). As a 
control, the level of polymerized α-tubulin in WT MEF cells 
expressing similar amounts of stathmin siRNA was not mark-
edly changed (57 ± 3.9% of total tubulin). These results indi-
cate a contribution of stathmin to the loss of polymerized tubulin 
in ∆St3 MEFs.
The contribution of stathmin activity to the migratory 
properties of MEFs was then examined. First, we showed that 
the expression of stathmin siRNA had no apparent effect on the 
ability of WT MEFs to migrate into a wound track (Fig. 6 D, 
i–iii). This correlated with the lack of effect of the stathmin 
siRNA on MT levels in the normal fi  broblast (Fig. 6 A). In con-
trast, the defi  ciency in ∆St3 MEF migration into a wound track 
was   partially reversed by down-regulating stathmin (Fig. 6 D, 
iv–vi). Quantitative analysis indicated 30–70% (P < 0.05 and 
P < 0.001, respectively) restoration in migration into the wound 
track by ∆St3 MEFs transfected with increasing concentrations 
of stathmin siRNA (Fig. 6 E). As an increased stathmin protein 
Figure 4.  Stat3 promotes MT formation. (A) WT (i), ∆St3 (ii), and ∆St3 MEF cells infected with a retrovirus expressing Stat3 (iii) were stained for acetylated 
α-tubulin. (B) ∆St3 MEF cells were infected either with a retrovirus expressing Stat3 (∆St3 + retrovirus) or an empty control vector (∆St3 + viral vector). 
Polymerized (P) and soluble (S) α-tubulin was then differentially extracted and analyzed by blotting. Stat3 expression was also conﬁ  rmed by   immunoblotting. 
Blots were reprobed for GAPDH as a loading control. WT and uninfected ∆St3 MEFs were analyzed simultaneously for comparison. (C) MCF-7 cells were 
transfected with a vector expressing human Stat3 siRNA (iv–vi) or an empty control vector (i–iii). Cells were then ﬁ  xed and stained for acetylated α-tubulin 
and Stat3. Arrows indicate cells with down-regulated expression of Stat3. (D and E) ∆St3 MEF cells were transiently transfected with Flag-tagged WT Stat3 
(i and ii), point mutated Stat3 Y705F (iii and iv), or an active form of Stat3 (St3C; v and vi). Cells were then stained for Stat3 protein, and MTs were stained 
with anti–α-tubulin (D) or anti-acetylated α-tubulin (E). Bars, 20 μm.STAT3 REGULATES MICROTUBULES • NG ET AL. 251
expression had minimal effects on WT MEF cell migration 
(Fig. S4, available at http://www.jcb.org/cgi/content/full/jcb.
200503021/DC1), these results suggest that excessive stathmin 
activity in a Stat3-null background is at least partially  responsible 
for attenuating cell migration. In support of this, we observed 
that expression of a constitutively active mutant of stathmin 
Figure 5.  Stat3 attenuates stathmin-induced MT depolymerization. (A) Schematic representation of truncated mutants of stathmin. Conserved serine/threo-
nine phosphorylation sites are also shown. (B) Myc-tagged stathmin mutants were transiently expressed in PC12 cells. Endogenous Stat3 was then immu  no-
precipitated, and the association of myc-tagged proteins was determined by immunoblotting. TCLs were also blotted for Stat3 and myc-tagged protein 
expression. (C) Coimmunoprecipitation of the myc-tagged full-length SCLIP, SCLIP-SLD, or stathmin with endogenous Stat3 was compared in WT MEF cells. 
(D) WT (i–iii, vii–ix, xiii, and xv) and ∆St3 MEFs (iv–vi, x–xii, xiv, and xvi) were transiently transfected with either myc-tagged full-length stathmin (i–vi and 
xiii–xvi) or SCLIP-SLD (vii–xii). Cells were then ﬁ  xed and stained with anti–α-tubulin and anti-myc. Bars, 20 μm. (E) The expression of myc-tagged stathmin 
and SCLIP-SLD in WT and ∆St3 MEFs were determined by blotting.JCB • VOLUME 172 • NUMBER 2 • 2006  252
(tetraA) prevented the migration of WT MEF cells into the 
wound track (Fig. S4). This correlated with the ability of stath-
min tetraA to disassemble MTs in positively transfected WT 
MEF cells (not depicted). Altogether, our results point to stath-
min as a possible downstream target of Stat3 in maintaining the 
MT array and normal cell migration.
Stat3 directly attenuates the 
MT-destabilizing activity of stathmin in vitro
We next sought to confi  rm that Stat3 could directly attenuate 
stathmin activity by using recombinant proteins in an in vitro 
tubulin assembly assay. GST-Stat3, GST-stathmin, and GST–
SCLIP-SLD were produced in E. coli and purifi  ed by binding 
to glutathione–Sepharose beads. GST-Stat3 was further purifi  ed 
by gel fi  ltration, whereas stathmin and SCLIP-SLD was gener-
ated by removing the GST tag by proteolytic cleavage. The fi  nal 
recombinant proteins were resolved by SDS-PAGE and stained 
by Coomassie blue (Fig. 7 A).
First, we demonstrated the normal kinetics of MT as-
sembly, which included an initial nucleation stage followed by 
rapid polymerization that reached steady-state equilibrium at a 
∆OD340 of 0.2–0.25 within 60 min under standard conditions 
(Fig. 7 B, control). Although including Stat3 did not affect the 
normal reaction, in the presence of stathmin, tubulin polymer-
ization was severely inhibited (Fig. 7 B) to a level similar to a 
negative control containing nocodazole (not depicted). In addi-
tion, the inhibitory effect of stathmin on tubulin assembly was 
demonstrated to be dose dependent (Fig. 7 C). Next, we investi-
gated the effect of GST-Stat3 in reversing stathmin attenuated 
MT assembly using different molar ratios of GST-Stat3 versus 
stathmin. We fi  rst showed that as a control, GST alone did 
not inhibit the activity of stathmin (Fig. 7 B). Subsequently, we 
Figure 6.  Stathmin disassembly of MTs and attenuation of 𝖫St3 MEF cell migration. (A) WT and (Β) ∆St3 MEFs were transfected with increasing amounts 
of stathmin siRNA (0–30 nM), and the amount of α-tubulin in polymerized (p) and soluble (s) fractions was determined. Stathmin expression was also 
determined by Western blotting. Reprobing for GAPDH served as a protein loading control. (C) Tubulin bands were quantiﬁ  ed by densitometric analysis, 
and polymerized tubulin was expressed as a percentage of total tubulin levels. *, P < 0.05; **, P < 0.01, as determined by paired t test analysis. (D) WT 
(i–iii) and ∆St3 (iv–vi) MEFs expressing stathmin siRNA (30 nM; iii and vi) or a random sequence control (ii and v) were subjected to in vitro wounding 
before phase-contrast analysis after 24 h. The ﬁ  elds in between the white lines indicate the wound track. Bar, 20 μm. (E) The number of cells in the wound 
track from 10 random separate ﬁ  elds were counted for each treatment and expressed as a mean ± SD (error bars). *, P < 0.0005; **, P < 0.001, as 
determined by a paired t test.STAT3 REGULATES MICROTUBULES • NG ET AL. 253
  observed that although relatively low levels of GST-Stat3 (1:30 
ratio to stathmin) had little effect, GST-Stat3 in a 1:5 molar ratio 
to stathmin restored MT polymerization to the same maximal 
level in comparison with the control (Fig. 7 D). These results 
indicated that GST-Stat3 reversed stathmin inhibition of MT 
polymerization in a dose-dependent manner. However, it was 
noticed that the normal polymerization kinetics were not com-
pletely restored. In the presence of GST-Stat3 and stathmin 
(1:5), the time required to reach maximum polymerization was 
>70 min compared with <40 min in the presence of tubulin 
alone (Fig. 7 D, control). Because of the low expression levels 
of the recombinant protein, a greater amount of GST-Stat3 
could not be used without altering the total reaction volume 
and, subsequently, normal MT assembly kinetics.
The antagonistic function of Stat3 was further demon-
strated by adding GST-Stat3 at  30 min after the commence-
ment of polymerization in the presence of stathmin. Upon 
adding Stat3, a reversal of stathmin that inhibited MT polymer-
ization was immediately evident (Fig. 7 E), indicating that Stat3 
could attenuate the interaction between stathmin and tubulin. 
As a control, GST had no such effect (Fig. 7 E). Finally, we 
showed that SCLIP-SLD, which does not interact with Stat3, 
can also inhibit MT assembly to a similar extent as stathmin but 
could not be attenuated when coincubated with GST-Stat3 (Fig. 
7 F). These data demonstrate that Stat3 regulates the MT poly-
merization via direct interaction with stathmin. Indeed, in these 
MT polymerization reactions, GST-Stat3 directly interacted 
with stathmin, as shown by GST pull-down assays (Fig. 7 G).
To further address the effect of stathmin and Stat3, MTs 
were assembled using rhodamine-labeled tubulin, and the pro-
ducts were examined by fl  uorescence microscopy. In the control 
reaction, large amounts of long MT strands were formed after 
30 min of incubation time (Fig. 7 H, i). In the presence of taxol, 
tubulin assembled into many short MT aggregates (Fig. 7 H, ii). 
This confi  rms the previously defi  ned mechanism of taxol action 
in promoting MT assembly through stabilizing short tubulin 
polymers (Morejohn and Fosket, 1984). This indicates that, in 
vitro, taxol promotes a rapid absorbance increase in the turbidi-
tometric assay through MT nucleation rather than elongation. 
As expected, incubating stathmin with tubulin prevented MT 
assembly, as shown by the lack of MTs after 30 min at 37°C 
(Fig. 7 H, iii) and the observation of only a few long MT strands 
after 60 min (Fig. 7 H, iv). However, preincubating stathmin 
with GST-Stat3 signifi  cantly rescued the assembly of MTs by 
30 min, which improved further after 60 min (Fig. 7 H, v and vi). 
Furthermore, unlike taxol-assembled MTs, MT strands rescued 
by GST-Stat3 were long and comparable with untreated control 
MTs (Fig. 7 H, compare vi with i). These results, together with 
those shown in Fig. 7 E, indicate that stathmin inhibits the de 
novo formation of MTs. These results also clearly demonstrate 
a direct role for Stat3 in antagonizing the MT-destabilizing 
effect of stathmin to promote MT assembly.
Discussion
In this study, we identifi  ed the MT-destabilizing protein stath-
min as a novel Stat3-interacting protein. To date, previously 
identifi  ed Stat3-interacting proteins have been concerned pri-
marily with modulating Stat3 activity (Chung et al., 1997; Col-
lum et al., 2000; Lufei et al., 2003). This does not appear to be 
the case with stathmin, as manipulating the expression of stath-
min failed to perturb the phosphorylation, nuclear translocation, 
or transcriptional activity of Stat3 (Fig. 2). Instead, we present 
evidence that the association of Stat3 with stathmin may be in-
volved in modulating the MT-destabilizing activity of the latter. 
Embryonic fi  broblasts lacking Stat3 clearly exhibited a dis-
rupted MT network with a lower level of polymerized and acet-
ylated tubulin, which was reversed upon the reintroduction of 
Stat3 (Figs. 3 and 4). These results provide clear evidence that 
Stat3 is necessary for maintaining proper MT organization. 
However, there does not appear to be an obvious effect on mi-
totic MTs, as spindle formation and cell division do not appear 
perturbed in ∆St3 MEFs (not depicted).
Stat3 had not been reported to directly associate with 
MTs. Our study supports this, as the pelleting of polymerized 
tubulin does not bring down Stat3 (Fig. 3 C). In addition, there 
was no obvious change in total tubulin protein (Fig. 3 B) or 
mRNA levels (not depicted) in ∆St3 cells. This suggests that 
Stat3 does not directly modulate MT stability or tubulin expres-
sion. In contrast, our study indicates that Stat3 binds the COOH-
terminal tubulin-binding domain of stathmin (Fig. 5), which is 
thought to contribute signifi  cantly, although not solely, to its 
MT-destabilizing activity (Curmi et al., 1997; Howell et al., 1999; 
Larsson et al. 1999). This suggests that Stat3 may compete for 
the tubulin-binding site to antagonize the MT-desta  bilizing ac-
tivity of stathmin. In support of this, we show that recombi-
nant Stat3 competitively binds and interferes with stathmin’s 
activity in vitro (Fig. 7), implicating stathmin as a direct target 
of Stat3 in maintaining MT morphology. Furthermore, tubulin 
polymerization is reestablished in ∆St3 cells by stathmin down-
regulation (Fig. 6). In addition, stathmin overexpression disas-
sembled MTs in ∆St3 but not WT MEFs (Fig. 5). Although an 
increase in stathmin expression would be expected to result in 
MT disassembly in the normal cells, the extent of perturbation 
exerted on the MT array by exogenous stathmin depends largely 
on the level of expression achieved (Marklund et al., 1994; 
Niethammer et al., 2004). In contrast, we found that a similar 
expression level of SCLIP-SLD destabilized MTs irrespective 
of the presence of Stat3 in vivo (Fig. 5). This was further con-
fi  rmed by the ability of recombinant Stat3 to attenuate the activ-
ity of stathmin, but not SCLIP-SLD, in vitro (Fig. 7 F). As the 
MT-destabilizing kinetics between these two highly homolo-
gous domains are similar in vitro (Fig. 7 F; Charbaut et al., 2001) 
and given their similar expression levels in vivo (Fig. 5 E), the 
main differentiating factor remains the expression of Stat3 in 
the MEF cells. However, as stathmin down-regulation only par-
tially reversed the defi  ciency in MT levels and cell migration 
(Fig. 6), stathmin-independent mechanisms perturbed by the 
loss of Stat3 remains a possibility. Collectively, we conclude 
that a direct binding of stathmin by Stat3 serves to maintain the 
interphase MT array and support cell migration.
During the preparation of this manuscript, a similar study 
reported an interaction between stathmin and p27
Kip1, a cyclin-
dependent kinase inhibitor protein (Baldassarre et al., 2005). JCB • VOLUME 172 • NUMBER 2 • 2006  254
Figure 7.  Stat3 attenuates stathmin MT-destabilizing activity in vitro. (A) Recombinant proteins (GST-Stat3, GST, stathmin, and SCLIP-SLD) used in the in vitro 
tubulin assembly experiments. (B) 300 μg tubulin was polymerized at 37°C in the presence of 35 μg GST-Stat3, 32 μg stathmin, 35 μg stathmin coincubated 
with GST, or an equivalent volume of buffer (control). (C) Tubulin was polymerized at 37°C in the presence of varying amounts of stathmin (1.9–30 μg). 
Polymerization in the presence of buffer alone was included as a positive control. (D) Tubulin was polymerized in the presence of 32 μg stathmin co-
incubated with varying molar ratios of GST-Stat3 as indicated. Assembly in the presence of buffer or stathmin alone was included as positive and negative 
controls, respectively. (E) Tubulin assembly was conducted in the presence of 32 μg stathmin for 28 min (arrow). 35 μg GST-Stat3 or 35 μg GST was then 
added, and the reactions continued up to 90 min. Buffer or stathmin alone was included as a control. (F) Tubulin was assembled in the presence of 35 μg 
GST-Stat3, 32 μg stathmin, 32 μg SCLIP-SLD alone, or SCLIP-SLD coincubated with 35 μg GST-Stat3. (G) The interactions between stathmin and GST-Stat3 
or GST in the in vitro MT polymerization assays were determined by GST pull-down. (H) 30 μg rhodamine-labeled tubulin was assembled at 37°C alone 
for 30 min (i), in the presence of 10 μM taxol for 30 min (ii), with 3.2 μg stathmin alone for 30 (iii) or 60 min (iv), or with stathmin preincubated with 
3.5 μg GST-Stat3 for 30 (v) or 60 min (vi) and analyzed by ﬂ  uorescence microscopy. Bar, 20 μm.STAT3 REGULATES MICROTUBULES • NG ET AL. 255
Although unclear, it remains possible that both proteins may 
be involved in regulating stathmin, depending on the cellular 
context. It is also interesting to note that p27
Kip1 expression 
is regulated by Stat3 (Klausen et al., 2000). In conjunction 
with this report, our current study supports the notion that the 
MT-destabilizing activity of stathmin may be regulated by 
protein–protein interaction in addition to serine/threonine 
phosphorylation. However, given that the nonphosphorylat-
able stathmin-tetraA constitutively active mutant could still 
disassemble MTs (not depicted) and halt migration in WT MEF 
cells (Fig. S4), serine phosphorylation clearly remains a key 
negative regulatory mechanism in stathmin function.
The loss of Stat3 severely affected the ability of MEFs to 
migrate into a wound track, which supports previous reports of 
Stat3 as a critical regulator of keratinocyte and ovarian cancer 
cell motility (Sano et al., 1999; Silver et al., 2004). As stathmin 
down-regulation promoted the migration of ∆St3 MEFs (Fig. 6), 
inhibition of stathmin by Stat3 may, at least, be partially in-
volved in maintaining cell motility in fi  broblasts. We have also 
reported that the down-regulation of stathmin by siRNA in WT 
MEFs did not lead to a noticeable effect on MT polymer levels 
or cell migration (Fig. 6). Although the reason for this is un-
clear, we can postulate that the majority of stathmin in the inter-
phasic cell may not be required for maintaining the MT array 
and may be kept inactive by negative regulatory mechanisms. In 
support of this was our observation that an increased expression 
of WT stathmin did not signifi  cantly perturb the MT array 
(Fig. 5) or migration (Fig. S4), suggesting that existing negative 
regulators of stathmin are suffi  cient for maintaining normal 
cell function. This is consistent with our observations that the 
wholesale loss of a negative regulator such as Stat3 would be 
detrimental to both the MT array and cell migration.
Some have made the reciprocal observation that an ele-
vated expression of stathmin contributes to promoting cell 
migration (Baldassarre et al., 2005; Giampietro et al., 2005). 
However, this is counterintuitive to evidence that localized MT 
stabilization promotes cell migration through the establishment 
of cell polarity and preservation of the leading edge (Palazzo 
et al., 2004; Wen et al., 2004). Furthermore, a reduced level of 
stathmin–tubulin interaction has been described at the leading 
edge (Niethammer et al., 2004). In addition, a mild nocodazole 
treatment has also been shown to severely reduce fi  broblast lo-
comotion (Liao et al., 1995). Thus, excessive stathmin activity 
would likely be antimigratory. In confi  rmation of this, the ex-
pression of a constitutively active stathmin mutant prevented 
the migration of WT cells into the wound track (Fig. S4). How-
ever, although seemingly paradoxical, a chronic loss of stath-
min activity, as is the case with stathmin-null fi  broblasts 
(Baldassarre et al., 2005), may also be detrimental to cell migra-
tion as a result of a reduction in MT dynamics. In support of 
this, an analogous effect with taxol treatment also leads to a halt 
in cell motility (Liao et al., 1995). Thus, it appears that relative 
stathmin activity, as opposed to expression levels themselves, 
may be the more critical determinant in maintaining cell migra-
tion. Collectively, we propose that Stat3 regulation of stathmin 
activity is required to maintain MT dynamics to promote nor-
mal cell movement.
Stat3 function has traditionally been described in regard 
to its nuclear gene-regulating activity (for review see Bromberg 
and Darnell, 2000; Levy and Darnell, 2002). Although our re-
sults do not exclude a contribution by the transcriptional activ-
ity of Stat3, the notion that the Stat3–stathmin interaction is at 
least partially responsible for regulating MT assembly repre-
sents a key cytoplasmic function for Stat3. In support of this, 
fractionation studies have shown that after activation, an esti-
mated 30% of Stats maximally and transiently accumulate in 
the nucleus (Carballo et al., 1999; Bienvenu et al., 2001) with a 
substantial amount of Stat3 remaining cytoplasmic. In addition, 
we have determined that intracellular Stat3, relative to stathmin, is 
present in suffi  cient amounts to antagonize the MT-destabilizing 
protein by direct interaction. Furthermore, the cytoplasmic 
  expression of the Stat3 Y705F mutant was suffi  cient to promote 
the formation of acetylated MTs (Fig. 4). Given that perturba-
tion of the MT network did not affect Stat3 activation (Fig. S1) 
and that stimulating Stat3 activity did not change MT polymer 
mass, the cytoplasmic and nuclear functions of Stat3 appear to 
be independent of one another.
In conclusion, our study has described a role for cytoplas-
mic Stat3 in mediating MT dynamics through functional inter-
action with a key MT-destabilizing protein, stathmin. MTs are 
central components of the cellular architecture required for pro-
liferation, differentiation, and migration. Our work presents a 
novel mechanism through which Stat3 may mediate these pro-
cesses in conjunction with its nuclear transcriptional activity.
Materials and methods
Yeast two-hybrid screening
Stat3395–770 was cloned into the pGBKT7 plasmid containing the GAL4 
DNA-binding domain and was used as bait in a yeast two-hybrid screen 
of a fetal mouse brain cDNA library (CLONTECH Laboratories, Inc.) as 
previously described (Lufei et al., 2003). After elimination of false positive 
clones by a β-gal colony lift-ﬁ  lter assay, plasmids were isolated from posi-
tive colonies, transformed into DH5α, puriﬁ  ed, and sequenced.
Plasmid construction
Stathmin, SCG10, and SCLIP were ampliﬁ  ed from a human fetal brain 
cDNA library (CLONTECH Laboratories, Inc.) by PCR with speciﬁ  c primers 
and subcloned into the pXJ40-myc vector with BamH1 and XhoI restriction 
enzymes. SCLIP-SLD and the truncated mutants of stathmin were subse-
quently generated by PCR, and the products were reinserted into pXJ40-
myc. Stat3C was constructed from pRC-CMV-Stat3 by site-directed 
mutagenesis as previously described (Bromberg et al., 1999). All con-
structs were subjected to restriction digest and full sequencing analysis.
Recombinant protein puriﬁ  cation
The GST-Stat3 fusion protein and the baculovirus-produced Stat3 were puri-
ﬁ  ed as previously described (Cao et al., 1996; Zhang et al., 2000). GST-
Stat3 was further puriﬁ  ed from cleavage products by fast protein liquid 
chromatography gel ﬁ   ltration through a Superdex HR200 column (GE 
Healthcare) equilibrated with 80 mM Pipes, pH 6.8, 1 mM EGTA, 5 mM 
MgCl2, 10% (vol/vol) glycerol, and 1 mM benzamidine. The column was 
calibrated with the markers dextran blue (2,000 kD), femtin (440 kD), and 
cytochrome C (14 kD). Fractions corresponding to full-length GST-Stat3 
were pooled and concentrated before use. The GST-stathmin and GST–
SCLIP-SLD expression plasmid were constructed by inserting stathmin and 
SCLIP-SLD cDNA fragment into pGEX-6P-1 (GE Healthcare) vector with 
BamH1 and XhoI restriction enzymes. Plasmids were transfected to E. coli, 
and the expression of GST fusion proteins was induced with 100 mM IPTG 
for 4 h. GST fusion proteins were puriﬁ   ed by binding to glutathione–
  Sepharose beads, eluted with 10 mM glutathione and 50 mM Tris-HCl, pH 
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and 10% (vol/vol) glycerol. GST was then removed by Precision Protease 
cleavage according to optimized conditions (GE Healthcare).
Cell culture, drug treatments, and transfection
MCF7, NSC34, and MEFs were maintained in DME containing 10% FBS 
and supplemented with penicillin/streptomycin and L-glutamine. PC12 
cells were similarly cultured but with an additional 5% (vol/vol) horse se-
rum. MTs were polymerized by 10 μM taxol and depolymerized by 10 μM 
nocodazole for 4 h at 37°C before cell lysis. Transient transfections 
were performed with LipofectAMINE 2000 (Invitrogen) according to the 
manufacturer’s instructions.
Immunoﬂ  uorescence microscopy
Cells were grown on glass coverslips overnight to subconﬂ  uency. Subse-
quent to cell treatments, cells were ﬁ  xed in 4% (wt/vol) PFA, permeabilized 
with 0.2% (vol/vol) Triton X-100 in PBS, and blocked with 10% (vol/vol) 
FCS in PBS. Cells were then stained with primary antibodies diluted 
(1:100) in 1% (wt/vol) BSA in PBS and detected withCy2/Cy3-conjugated 
secondary antibodies (1:400 in 0.1% [wt/vol] BSA in PBS). The cells 
were then mounted and examined on a confocal microscope (MRC1024; 
Bio-Rad Laboratories) using 40× NA 1.00 and 100× NA 1.25 oil 
immersion objectives (Carl Zeiss MicroImaging, Inc.) on an upright 
microscope (Axioplan2; Carl Zeiss MicroImaging, Inc.). Images were 
collected and processed using Lasersharp 2000 and Adobe Photoshop 
version 6.0, respectively.
Cell migration assay
Assay of cell migration into a wound area was performed as previously 
described (Sano et al., 1999) with slight modiﬁ  cations. In brief, WT and 
∆St3 MEF cells were grown to subconﬂ  uency on collagen (type I)-coated 
culture dishes (Iwaki). The cells were starved of serum for 24 h and treated 
with mitomycin C for 90 min to arrest cell proliferation. A wound track was 
then introduced by scraping the cell monolayer with a yellow pipette tip. 
Cells were cultured for a further 24–48 h before phase-contrast analysis.
siRNA
The siRNA expression vector containing a 21-nt target sequence for human 
Stat3 was constructed by insertion into pBS/U6 vector (a gift from Y. Shi, 
Harvard Medical School, Boston, MA) in two separate steps as previ-
ously described (Sui et al., 2002). The ﬁ  rst annealed oligonucleotide pairs 
(5′-G  G  C  G  T  C  C  A  T  C  C  T  G  T  G  G  T  A  C  A  A  -3′ and 5′-A  G  C  T  T  T  G  T  A  C  C  A  C  A  G  -
G  A  T  G  G  A  C  G  C  C  -3′) were digested with ApaI (blunted) and HindIII. The 
inverted motifs that contained the six-nt spacer and ﬁ  ve Ts (5′-A  G  C  T  T  T  G  T  A-
C  C  A  C  A  G  G  A  T  G  G  A  C  G  C  C  C  T  T  T  T  T  G  -3′ and 5′-A  A  T  T  C  A  A  A  A  A  G  G  G  C  G  T  C-
C  A  T  C  C  T  G  T  G  G  T  A  C  A  A  -3′) were then subcloned into the intermediate 
plasmid (HindIII and EcoRI sites) to generate pBS/U6-hu Stat3 siRNA. 
A Basic Local Alignment Search Tool search of all target sequences showed 
no signiﬁ  cant sequence homology with other genes. All siRNA expression 
vectors were conﬁ  rmed by sequence analysis of the target insert. The mu-
rine stathmin synthetic siRNA (Santa Cruz Biotechnology, Inc.) was used 
according to the manufacturer’s instructions.
In vivo polymerized tubulin assay
The in vivo assay of polymerized tubulin was performed as previously de-
scribed (Minotti et al., 1991). In brief, MEF cells were scraped into a MT-
stabilizing buffer (0.1 M Pipes, pH 6.9, 2 M glycerol, 5 mM MgCl2, 2 mM 
EGTA, 0.5% Triton X-100, and protease inhibitors) supplemented with 
4 μM taxol to maintain MT stability during isolation. The supernatant con-
taining solubilized tubulin was clariﬁ  ed by centrifugation (20,000 g for 
45 min) and separated from the pellet containing sedimented polymerized 
tubulin. The pellet was washed once in MT-stabilizing buffer before being 
denatured in laemmli buffer.
In vitro tubulin polymerization
The in vitro kinetics of MT assembly was measured using the Tubulin 
Polymerization Assay kit (Cytoskeleton, Inc.) according to the manufac-
turer’s instructions. In brief, the assembly of 300 μg tubulin in 100 μl 
tubulin assembly buffer (80 mM Pipes, pH 6.8, 0.5 mM EGTA, 2 mM 
MgCl2, 1 mM GTP, and 10% vol/vol glycerol) into MTs was started by 
incubating at 37°C. Absorbance at 340 nm was then measured every 
minute for up to 90 min in a temperature-controlled 96-well microtitre 
plate spectrophotometer (Genios; Tecan). Unless otherwise stated, re-
combinant proteins were coincubated for 10 min before the addition to 
tubulin. For ﬂ  uorescence studies, 2 μg/μl tubulin was polymerized with 
rhodamine-labeled tubulin in a 4:1 ratio at 37°C for 30 or 60 min. MTs 
were then immediately spotted on a glass slide, an equal volume of Gel 
Mount (Biomeda) was added, and a coverslip was mounted. Images 
were then collected on a confocal microscope (MRC1024; Bio-Rad Lab-
oratories) using a 100× NA 1.25 oil immersion objective (Carl Zeiss 
MicroImaging, Inc.) on an upright microscope (Axioplan2; Carl Zeiss 
MicroImaging, Inc.).
Online supplemental material
Fig. S1 shows that the MT polymerization state is independent of Stat3 ac-
tivation. Fig. S2 shows that Stat3 does not associate with tubulin and that 
its binding to stathmin does not require the MT network. Fig. S3 indicates 
the quantiﬁ  cation of Stat3 and stathmin protein in PC12 cells, and Fig. S4 
shows that constitutively active stathmin attenuates cell migration. Online 
supplemental material is available at http://www.jcb.org/cgi/content/
full/jcb.200503021/DC1.
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